| 000 | 01679 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515123429.0 | ||
| 264 | 0 | _c20090408 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1531-8257 | ||
| 024 | 7 |
_a10.1002/mds.22163 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTarnacka, Beata | |
| 245 | 0 | 0 |
_aMR spectroscopy in monitoring the treatment of Wilson's disease patients. _h[electronic resource] |
| 260 |
_bMovement disorders : official journal of the Movement Disorder Society _cAug 2008 |
||
| 300 |
_a1560-6 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntidotes _xtherapeutic use |
| 650 | 0 | 4 |
_aAspartic Acid _xanalysis |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCholine _xanalysis |
| 650 | 0 | 4 |
_aCreatine _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlutamic Acid _xanalysis |
| 650 | 0 | 4 |
_aHepatolenticular Degeneration _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
| 650 | 0 | 4 |
_aMagnetic Resonance Spectroscopy _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPenicillamine _xtherapeutic use |
| 650 | 0 | 4 | _aProtons |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSzeszkowski, Wojciech | |
| 700 | 1 | _aGolebiowski, Marek | |
| 700 | 1 | _aCzlonkowska, Anna | |
| 773 | 0 |
_tMovement disorders : official journal of the Movement Disorder Society _gvol. 23 _gno. 11 _gp. 1560-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/mds.22163 _zAvailable from publisher's website |
| 999 |
_c18031879 _d18031879 |
||